A groundbreaking new drug that slows down the development of type 1 diabetes has been licensed for use in the UK.
Teplizumab can allow patients to live “normal lives” without the need for insulin injections.
A groundbreaking new drug that slows down the development of type 1 diabetes has been licensed for use in the UK.
Teplizumab can allow patients to live “normal lives” without the need for insulin injections.